Thermo Fisher Scientific Contract Assets increased by 2.8% to $1.67B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 16.1%, from $1.44B to $1.67B. Over 5 years (FY 2020 to FY 2025), Contract Assets shows an upward trend with a 17.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests strong project progress or service delivery ahead of billing cycles; a decrease may indicate slower project completion or faster billing.
This represents the entity's right to consideration in exchange for goods or services that the entity has transferred to...
Standard for companies with long-term service or construction-type contracts.
contract_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $804.00M | $808.00M | $968.00M | $1.06B | $1.15B | $1.25B | $1.31B | $1.38B | $1.47B | $1.47B | $1.44B | $1.42B | $1.49B | $1.54B | $1.44B | $1.37B | $1.44B | $1.62B | $1.67B |
| QoQ Change | — | +0.5% | +19.8% | +9.9% | +7.8% | +8.8% | +5.1% | +4.8% | +6.7% | -0.1% | -1.5% | -1.5% | +4.6% | +3.6% | -6.9% | -4.8% | +5.5% | +12.4% | +2.8% |
| YoY Change | — | — | — | — | +42.7% | +54.5% | +35.5% | +29.2% | +27.9% | +17.4% | +10.0% | +3.4% | +1.4% | +5.2% | -0.6% | -3.9% | -3.1% | +5.1% | +16.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.